However, Nrf2 in the advanced stages of the cancer disease has an opposite role, since its activation has been shown to be involved in modulating cell proliferation, EMT, migration, invasion, angiogenesis, and tumor progression [63,142] as well as chemoresistance and radioresistance of various malignant tumors [143,144]. The gene discussed is NFE2L2; the disease is cancer.